Development in wastewater treatment research and processes : innovative trends in removal of refractory pollutants from pharmaceutical wastewater /
Development in Wastewater Treatment Research and Processes: Innovative Trends in Removal of Refractory Pollutants from Pharmaceutical Waste Water sorts out emerging and burning issues faced by the pharmaceutical industry, along with common effluent treatment plans.
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Amsterdam :
Elsevier,
2024.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover
- Development in Wastewater Treatment Research and Processes
- Development in Wastewater Treatment Research and Processes
- Contents
- Contributors
- 1
- Pharmaceutical wastewater management: Physicochemical, chemical, and biological approaches
- 1. Introduction
- 2. Pharmaceutical compounds present in the wastewater
- 3. Physicochemical approach for the elimination of emerging contaminants
- 3.1 Coagulative precipitation
- 3.2 Electrocoagulation
- 3.3 Sedimentation
- 3.4 Floatation
- 3.5 Electrolysis
- 3.6 Adsorption
- 3.7 Membrane separation
- 4. Chemical approach for removing emerging contaminants
- 4.1 Advanced oxidation
- 4.2 Wet air oxidation (WAO)
- 4.3 Supercritical water oxidation (SCWO)
- 4.4 Electro-fenton reagent
- 4.5 Biological electro fenton (Bio-EF)
- 4.6 Photocatalytic oxidation
- 4.7 Ultrasound oxidation (UAO)
- 4.8 Electrochemical oxidation
- 4.9 Ozonation
- 4.10 Perozonation
- 4.11 Iron-carbon method
- 4.12 Chlorination
- 4.13 Flocculation
- 5. Biological treatment approach for the removal of emerging contaminants
- 5.1 Activated sludge process (ASP)
- 5.2 Sequence batch reactor (SBR)
- 5.3 Moving bed biofilm reactor (MBBR)
- 5.4 Membrane bioreactor (MBR)
- 5.5 Trickling filter (TF)
- 5.6 Anaerobic treatment system
- 5.6.1 Hybrid anaerobic+biological system
- 5.6.2 Hybrid anaerobic+chemical/physical systems
- 5.7 Hybrid biological-physical- treatment processes
- 5.8 Hybrid biological-physical-chemical treatment processes
- 6. Phyto-remediation approaches for pharmaceuticals wastewater treatment
- 7. Mycoremediation approaches for pharmaceuticals wastewater treatment
- 8. Phyco-remediation approaches for pharmaceutical wastewater treatment
- 9. Pharmaceuticals wastewater treatment during the COVID-19 pandemic.
- 10. Clustered regularly interspaced palindromic repeats (CRISPR) assisted bioremediation approach
- 11. Conclusion
- References
- 2
- Applications of ultrafiltration, nanofiltration, and reverse osmosis in pharmaceutical wastewater treatment
- 1. Introduction
- 2. Membrane separation approaches
- 3. Removal of emerging pharmaceutical contaminants by nanofiltration membrane system
- 4. Removal of the emerging pharmaceutical contaminants by ultrafiltration membrane system
- 5. Removal of emerging contaminants by reverse osmosis membrane system
- 6. Conclusion
- References
- 3
- Recent advancement in bioremediation of pharmaceutical wastewater
- 1. Introduction
- 2. Refractory pollutants
- 3. Pharmaceutical industry wastewater (PIWW)
- 4. Bioremediation
- 4.1 Bioadsorption
- 4.2 Bioaccumulation
- 4.3 Biodegradation
- 4.4 Photo-biodegradation
- 4.5 Volatilization
- 5. Microorganisms involved in bioremediation of PIWW
- 5.1 Bacterial bioremediation
- 5.2 Fungal bioremediation
- 5.3 Phycoremediation
- 5.4 Phytoremediation
- 6. Membrane bioreactors
- 7. Enzyme-driven bioremediation
- 8. Future perspective of bioremediation in PIWW treatment
- 9. Conclusions
- References
- 4
- Hybrid membrane processes equipped with crystallization unit for a simultaneous recovery of freshwater and mine ...
- 1. Introduction
- 2. Principles of membrane crystallization
- 2.1 Module configurations in membrane distillation crystallization
- 2.1.1 DCMD
- 2.1.2 AGMD
- 2.1.3 VMD
- 2.1.4 SGMD
- 2.2 Process of crystallization and precipitation
- 2.3 Factors affecting crystallization
- 2.3.1 Temperature
- 2.3.2 Flowrate
- 2.3.3 Concentration of the feed solution
- 3. Membranes used in membrane crystallization
- 4. Fouling and wetting in membrane crystallization
- 5. Fouling and wetting mitigation strategies
- 5.1 Membrane modification.
- 5.2 Membrane cleaning
- 5.3 Pre-treatment processes
- 6. Application of membrane crystallization for the treatment of wastewater
- 7. Conclusion
- References
- 5
- Advanced (nano)materials
- 1. Introduction
- 2. Green nanotechnology
- 3. Green nanomaterial preparation
- 3.1 Physical method
- 4. Chemical method
- 5. Biological method
- 6. Biosynthesis of NPs using microorganisms
- 6.1 Synthesis of nanoparticles using fungi
- 7. Synthesis of nanoparticles using yeast
- 8. Synthesis of nanoparticles using bacteria
- 9. Synthesis of nanoparticles using actinomycetes
- 10. Synthesis of nanoparticles using plant
- 11. Applications of green nanomaterials
- 12. Environmental cleanup
- 13. Nanoremediation
- 14. Nanomaterials as adsorbents for water treatment
- 15. Nanomaterials in photocatalysis
- 16. Copper oxide in photocatalysis
- 17. Nanosized iron oxides
- 18. Magnesium oxide NPs (MgO-NPs)
- 19. Nanocomposites in water treatment
- 20. Nanocomposite membrane
- 21. Magnetic nanocomposites
- 22. Chitosan NPs
- 23. Cellulose based nanoadsorbent
- 24. Dendrimer nanoadsorbent
- 25. Major problems in photocatalysis processes
- 26. Reusability of nanocomposites
- 27. Disinfection
- 28. Conclusion
- References
- 6
- Removal of pharmaceutical contaminants from wastewater using activated sludge process
- 1. Introduction
- 1.1 Pharmaceutical manufacturing industries
- 1.2 Human and animal excretions
- 1.3 Hospital and clinic effluents
- 2. Major units of activated sludge process based wastewater treatment
- 2.1 Screening
- 2.2 Grit chamber
- 2.3 Primary settling tank
- 2.4 Aeration tank
- 2.5 Secondary clarifier
- 3. Removal of pharmaceutical contaminants by activated sludge process
- 3.1 Hydraulic retention time (HRT)
- 3.2 Sludge retention time (SRT)
- 3.3 Redox conditions and temperature.
- 4. Removal process in ASP for pharmaceuticals
- 4.1 Biodegradation
- 4.2 Sorption
- 5. Techniques to enhance elimination of pharmaceutical in ASP
- 5.1 Activated carbon insertion
- 5.2 Hybridization with ASP
- 6. Conclusion
- References
- 7
- Bacteria mediated cadmium removal for wastewater treatment
- 1. Introduction
- 2. Cadmium toxicity
- 3. Conventional methods of cadmium removal
- 4. Bacteria mediated cadmium removal
- 5. Conclusions and future perspectives
- References
- 8
- Oxidation and advanced oxidation processes in pharmaceutical wastewater treatment
- 1. Introduction
- 2. Organic contaminants in waste water
- 3. Oxidation processes
- 4. Advance oxidation processes
- 5. Principle and types of AOP
- 6. Mechanism of AOPs
- 7. Advanced AOPs catalyzed by hydrogen peroxide
- 8. AOPs using UV radiation
- 9. Strategies for efficient optimization of AOPs
- 10. Merits of AOPs
- 11. Limitations of AOPs
- 12. Studies on AOPs for waste water treatment
- 13. Conclusion and future trend
- References
- 9
- Nanomaterials for the removal of pollutants from pharmaceutical wastewater
- 1. Introduction
- 2. Physio-chemical properties of pharmaceutical pollutants
- 3. Toxicological impact of pharmaceutical pollutants on ecosystem
- 4. Synthesis techniques of nanostructure materials
- 4.1 Chemical vapor deposition
- 4.2 Ball milling
- 4.3 Pyrolysis
- 4.4 Hydrothermal carbonization
- 4.5 Exfoliation
- 5. Mechanism behind the removal of contaminates by nanomaterials
- 6. Application of nanomaterials for the removal of pharmaceuticals
- 6.1 Carbon based nanomaterials
- 6.1.1 Carbon nanotubes
- 6.1.2 GO based nanomaterials
- 6.1.3 RGO based nanomaterials
- 6.2 Metal-based nanomaterials
- 7. Limitations
- 8. Conclusion and prospects
- References.
- 10
- Bio nanotechnology: An emerging tools to remove refractory pollutant from pharmaceutical wastewater
- 1. Introduction
- 2. Methods for treatment of pharmaceutical waste water
- 3. Nanotechnology
- 4. Synthesis of nanoparticles
- 4.1 Nanoparticles produced by plants
- 5. Bacteria-generated nanoparticles
- 6. Yeast and fungal nanoparticles
- 7. Nanotechnology for bioremediation
- 8. Different nanomaterials and treatment of pharmaceutical waste water
- 9. Nanofilter membrane bioreactor
- 10. Nanoadsorbants
- 11. Nanocatalyst
- 12. Conclusion
- References
- 11
- Bioremediation of pharmaceutical contaminants from wastewater by mushrooms
- 1. Introduction
- 2. Pharmaceutical residues
- 3. Wastewater treatment
- 4. Mushrooms in bioremediation of pharmaceutical contaminants from wastewater
- 4.1 Pleurotus sp.
- 4.2 Trametes versicolor
- 4.3 Phanerochaete chrysosporium
- 4.4 Agaricus bisporus and Lentinula edodes
- 5. Perspectives and conclusions
- References
- 12
- Microbial bioremediation potentials for refractory pollutants removal from pharmaceutical wastewater
- 1. Introduction
- 2. Nature and origin of pharmaceutical wastes
- 3. Bioremediation in treatment of pharmaceutical wastes
- 3.1 Bacteria and actinomycetes in bioremediation
- 3.2 Ultrafiltration membrane biological reactor based on nitrifying bacteria
- 3.3 Fungal bioremediation
- 3.4 Microalgal bioremediation (phycoremediation)
- 3.5 Technologies used to improve microbial bioremediation
- 4. Future prospects and conclusion
- References
- 13
- Innovative technologies for emerging issues in pharmaceuticals
- 1. Introduction
- 2. State of the art on the occurrence of pharmaceuticals all over the world
- 3. New emerging technologies for the removal of pharmaceuticals from the environment.